What is Praxis Precision Medicines, Inc.'s trading assets?

Praxis Precision Medicines, Inc. (PRAX) reported trading assets of $250.53M in Q1 2026.

How has Praxis Precision Medicines, Inc.'s trading assets changed year-over-year?

Praxis Precision Medicines, Inc.'s trading assets increased by 54.2% year-over-year, from $162.42M to $250.53M.

What does trading assets mean?

Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.

Praxis Precision Medicines, Inc. PRAX Trading assets

Trading assets at other companies

BiogenBIIB

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$105.9M-41.7%

Net income-$92.6M-33.6%

EPS (diluted)-$3.20+2.7%

Balance sheet

See full

Cash & equivalents$536.7M+223%

Total debt$1.4M+31.3%

Total equity$1.4B+221%

Total assets$1.5B+205%

Cash flow

See full

Operating cash flow-$86.2M-62.5%

CapEx$62.0K—

Free cash flow-$86.2M-62.6%

Valuation

See full

Market cap$7.87B+1,075%

Enterprise value$7.34B+1,309%

Profitability

See full

Operating margin-3,927.5%-1,497pp

Net margin-3,658.5%-1,388pp

FCF margin-3,067.4%-1,030pp

Returns & leverage

See full

Return on equity-35.3%-10.9pp

Debt / equity0×0.0×

Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s trading assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s trading assets?: Praxis Precision Medicines, Inc. (PRAX) reported trading assets of $250.53M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s trading assets changed year-over-year?: Praxis Precision Medicines, Inc.'s trading assets increased by 54.2% year-over-year, from $162.42M to $250.53M.
What does trading assets mean?: Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.